Home » Esmee Scriven

Esmee Scriven

Senior Analyst

Esmee Scriven is a Senior Analyst at CBPartners.

Connect with Esmee Scriven



Published Articles

KYMRIAH and TRELEGY Become the First Drugs to Undergo Japan’s New CEA System

What can be learned from the first use of Japan's new Cost-Effectiveness Assessment (CEA) system? Read CBPartners' infographic here.

Opportunities and Barriers for Biosimilar Uptake in the USA

In the first of a multi-part biosimilar podcast series, CBPartners Healthcare Consultants are joined by special guest Dr. Bhavesh Shah, Senior Director of Pharmacy Strategy at Boston Medical Center, to explore the evolving biosimilar landscape in the USA.

5 Opportunities to Take Advantage of During a Healthcare Consulting Internship

Two individuals who completed the Summer Analyst Program and have returned as full-time Analysts share advice on how to make the most out of a healthcare consulting internship based on their personal experiences.

The UK Introduces New Access and Licensing Pathway for Innovative Medicines